{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:38:01Z","timestamp":1793738281610,"version":"4.6.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2TR001874"],"award-info":[{"award-number":["KL2TR001874"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bpa.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T22:15:56Z","timestamp":1500329756000},"page":"153-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Long-term management of end-stage heart failure"],"prefix":"10.1016","volume":"31","author":[{"given":"Marlena V.","family":"Habal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7510-075X","authenticated-orcid":false,"given":"A. Reshad","family":"Garan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.bpa.2017.07.003_bib1","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"issue":"27","key":"10.1016\/j.bpa.2017.07.003_bib2","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.bpa.2017.07.003_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cardfail.2015.04.013","article-title":"Advanced (stage D) heart failure: a statement from the heart failure society of America guidelines committee","volume":"21","author":"Fang","year":"2015","journal-title":"J\u00a0Card Fail"},{"issue":"4","key":"10.1016\/j.bpa.2017.07.003_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1751-7133.2011.00246.x","article-title":"Who has advanced heart failure?: definition and epidemiology","volume":"17","author":"Abouezzeddine","year":"2011","journal-title":"Congest Heart Fail"},{"issue":"12","key":"10.1016\/j.bpa.2017.07.003_bib5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.bpa.2017.07.003_bib6","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.bpa.2017.07.003_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.carpath.2011.11.007","article-title":"The pathophysiology of heart failure","volume":"21","author":"Kemp","year":"2012","journal-title":"Cardiovasc Pathol"},{"issue":"10","key":"10.1016\/j.bpa.2017.07.003_bib8","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0735-1097(03)00309-7","article-title":"Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure","volume":"41","author":"Nohria","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.bpa.2017.07.003_bib9","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/CIRCULATIONAHA.104.478321","article-title":"Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant","volume":"113","author":"Stevenson","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bpa.2017.07.003_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.bpa.2017.07.003_bib11","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial","volume":"294","author":"Binanay","year":"2005","journal-title":"JAMA"},{"issue":"9766","key":"10.1016\/j.bpa.2017.07.003_bib12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.bpa.2017.07.003_bib13","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.bpa.2017.07.003_bib14","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.bpa.2017.07.003_bib15","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0735-1097(02)02560-3","article-title":"Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients","volume":"40","author":"Morrison","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.bpa.2017.07.003_bib16","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","article-title":"Myocardial viability and survival in ischemic left ventricular dysfunction","volume":"364","author":"Bonow","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.bpa.2017.07.003_bib17","first-page":"281","article-title":"An approach to the rational use of revascularization in heart failure patients","volume":"30","author":"Rouleau","year":"2014","journal-title":"Can J Cardiol"},{"issue":"9867","key":"10.1016\/j.bpa.2017.07.003_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(13)60108-7","article-title":"Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II","volume":"381","author":"Farooq","year":"2013","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.bpa.2017.07.003_bib19","first-page":"1482","article-title":"Canadian Cardiovascular Society\/Canadian Association of Interventional Cardiology\/Canadian Society of Cardiac Surgery position statement on revascularization\u2013multivessel coronary artery disease","volume":"30","author":"Teo","year":"2014","journal-title":"Can J Cardiol"},{"issue":"1046","key":"10.1016\/j.bpa.2017.07.003_bib20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/postgradmedj-2011-130698","article-title":"Reversible heart failure: toxins, tachycardiomyopathy and mitochondrial abnormalities","volume":"88","author":"Morris","year":"2012","journal-title":"Postgrad Med J"},{"issue":"22","key":"10.1016\/j.bpa.2017.07.003_bib21","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.bpa.2017.07.003_bib22","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","author":"Group CTS","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"9386","key":"10.1016\/j.bpa.2017.07.003_bib23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.bpa.2017.07.003_bib24","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A\u00a0randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"9386","key":"10.1016\/j.bpa.2017.07.003_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"issue":"9169","key":"10.1016\/j.bpa.2017.07.003_bib26","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in congestive heart failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"9146","key":"10.1016\/j.bpa.2017.07.003_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.bpa.2017.07.003_bib28","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.bpa.2017.07.003_bib29","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.105.582320","article-title":"Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the Randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III","volume":"112","author":"Willenheimer","year":"2005","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.bpa.2017.07.003_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.bpa.2017.07.003_bib31","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.bpa.2017.07.003_bib32","first-page":"e282","volume":"134","author":"Writing Committee","year":"2016","journal-title":"Circulation"},{"issue":"9744","key":"10.1016\/j.bpa.2017.07.003_bib33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.bpa.2017.07.003_bib34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"Digitalis Investigation","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.bpa.2017.07.003_bib35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/FJC.0000000000000274","article-title":"Digoxin is associated with increased all-cause mortality in patients with atrial fibrillation regardless of concomitant heart failure: a meta-analysis","volume":"66","author":"Wang","year":"2015","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"24","key":"10.1016\/j.bpa.2017.07.003_bib36","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study","volume":"314","author":"Cohn","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.bpa.2017.07.003_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","article-title":"A\u00a0comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure","volume":"325","author":"Cohn","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.bpa.2017.07.003_bib38","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.bpa.2017.07.003_bib39","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.bpa.2017.07.003_bib40","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.bpa.2017.07.003_bib41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.bpa.2017.07.003_bib42","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.healun.2006.06.005","article-title":"Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates\u20132006","volume":"25","author":"Gronda","year":"2006","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"10","key":"10.1016\/j.bpa.2017.07.003_bib43","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jchf.2016.05.003","article-title":"Implantable cardioverter-defibrillator use in patients with left ventricular assist devices: a systematic review and meta-analysis","volume":"4","author":"Vakil","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"25","key":"10.1016\/j.bpa.2017.07.003_bib44","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jacc.2013.04.020","article-title":"Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?","volume":"61","author":"Garan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.bpa.2017.07.003_bib45","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.bpa.2017.07.003_bib46","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.bpa.2017.07.003_bib47","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.bpa.2017.07.003_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5664\/jcsm.27076","article-title":"The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers","volume":"4","author":"MacDonald","year":"2008","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"13","key":"10.1016\/j.bpa.2017.07.003_bib49","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022479","article-title":"Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea","volume":"348","author":"Kaneko","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.bpa.2017.07.003_bib50","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.bpa.2017.07.003_bib51","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002897","article-title":"Preoperative proteinuria and reduced glomerular filtration rate predicts renal replacement therapy in patients supported with continuous-flow left ventricular assist devices","volume":"9","author":"Topkara","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"22","key":"10.1016\/j.bpa.2017.07.003_bib52","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.jacc.2013.02.064","article-title":"The MELD scoring system and the prediction of outcomes in heart failure patients: what we have learned from the hepatologists","volume":"61","author":"Eisen","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.bpa.2017.07.003_bib53","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.healun.2012.02.008","article-title":"Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction","volume":"31","author":"Chokshi","year":"2012","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"12","key":"10.1016\/j.bpa.2017.07.003_bib54","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.bpa.2017.07.003_bib55","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bpa.2017.07.003_bib56","first-page":"3","article-title":"The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications","volume":"31","author":"Moe","year":"2015","journal-title":"Can J Cardiol"},{"issue":"25","key":"10.1016\/j.bpa.2017.07.003_bib57","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.bpa.2017.07.003_bib58","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency dagger","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.bpa.2017.07.003_bib59","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.bpa.2017.07.003_bib60","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJM199511023331806","article-title":"A\u00a0multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure","volume":"333","author":"Rich","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.bpa.2017.07.003_bib61","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"O'Connor","year":"2009","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.bpa.2017.07.003_bib62","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/eurjhf\/hfq056","article-title":"Exercise training for systolic heart failure: cochrane systematic review and meta-analysis","volume":"12","author":"Davies","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.bpa.2017.07.003_bib63","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/01.CIR.83.3.778","article-title":"Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure","volume":"83","author":"Mancini","year":"1991","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.bpa.2017.07.003_bib64","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1161\/01.CIR.95.12.2660","article-title":"Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation","volume":"95","author":"Aaronson","year":"1997","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bpa.2017.07.003_bib65","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.bpa.2017.07.003_bib66","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/CIRCHEARTFAILURE.112.000043","article-title":"Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review","volume":"6","author":"Alba","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"18","key":"10.1016\/j.bpa.2017.07.003_bib67","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000164270.72123.18","article-title":"Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers","volume":"111","author":"O'Neill","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.bpa.2017.07.003_bib68","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/eurjhf\/hfp041","article-title":"Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology","volume":"11","author":"Jaarsma","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.bpa.2017.07.003_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"2","key":"10.1016\/j.bpa.2017.07.003_bib70","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 international society for heart and lung transplantation guidelines for mechanical circulatory support: executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"23","key":"10.1016\/j.bpa.2017.07.003_bib71","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jacc.2015.04.039","article-title":"Left ventricular assist devices: a rapidly evolving alternative to transplant","volume":"65","author":"Mancini","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.bpa.2017.07.003_bib72","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cardfail.2012.07.007","article-title":"Investigating pain in heart failure patients: the pain assessment, incidence, and nature in heart failure (PAIN-HF) study","volume":"18","author":"Goodlin","year":"2012","journal-title":"J\u00a0Card Fail"},{"issue":"4","key":"10.1016\/j.bpa.2017.07.003_bib73","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cardfail.2008.01.008","article-title":"Investigating pain in heart failure patients: rationale and design of the Pain Assessment, Incidence & Nature in Heart Failure (PAIN-HF) study","volume":"14","author":"Goodlin","year":"2008","journal-title":"J\u00a0Card Fail"}],"container-title":["Best Practice & Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689617300435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689617300435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:19:26Z","timestamp":1776410366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689617300435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1521689617300435"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2017.07.003","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term management of end-stage heart failure","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2017.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}